MR PHARM 741 LIMITED

Company Information
for the year from 1 November 2024 to 31 October 2025


Director	RASUL, Muniba


Registered Number	SC784782 (Scotland)

Statement of Financial Position
31 October 2025

	2025 £	2024 £

Fixed Assets	543	926

Current Assets	11,477	6,877
Creditors amounts falling due within one year	(5,034)	(3,607)
Net current assets (liabilities)	6,443	3,270

Total assets less current liabilities	6,986	4,196

Accruals and deferred income	(990)	(990)
Net assets (liabilities)	5,996	3,206
Capital and reserves	5,996	3,206

The company is a private company limited by shares and registered in Scotland. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Average number of employees
The average number of persons employed by the company in the period was 0 (previous period: 0).
Directors advances, credits and guarantees
Included in other Creditors at the year end is an amount of £1,241 (2024 : £121) due from the director.

The financial statements were approved and authorised for issue by the Director on 28 July 2026, and are signed on its behalf by:

RASUL, Muniba
Director
Registered Company No. SC784782